|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003232,
umls-concept:C0005953,
umls-concept:C0015967,
umls-concept:C0027947,
umls-concept:C0183683,
umls-concept:C0344211,
umls-concept:C0355642,
umls-concept:C0439859,
umls-concept:C0442027,
umls-concept:C0445202,
umls-concept:C0677582,
umls-concept:C1171411,
umls-concept:C1317973,
umls-concept:C1328050,
umls-concept:C1518896,
umls-concept:C1521721,
umls-concept:C1705294,
umls-concept:C1880496
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1994-5-23
|
|
pubmed:abstractText |
We studied the effectiveness of prophylactic oral ciprofloxacin and rifampin on fever prevention in patients undergoing autologous bone marrow transplantation (ABMT) for breast cancer. Furthermore, we evaluated the toxicity and efficacy of empiric once-daily vancomycin and tobramycin for febrile neutropenia.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1005-11
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:8164024-Administration, Oral,
pubmed-meshheading:8164024-Adult,
pubmed-meshheading:8164024-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8164024-Bacterial Infections,
pubmed-meshheading:8164024-Bone Marrow Purging,
pubmed-meshheading:8164024-Bone Marrow Transplantation,
pubmed-meshheading:8164024-Breast Neoplasms,
pubmed-meshheading:8164024-Ciprofloxacin,
pubmed-meshheading:8164024-Drug Administration Schedule,
pubmed-meshheading:8164024-Drug Therapy, Combination,
pubmed-meshheading:8164024-Female,
pubmed-meshheading:8164024-Fever,
pubmed-meshheading:8164024-Humans,
pubmed-meshheading:8164024-Injections, Intravenous,
pubmed-meshheading:8164024-Middle Aged,
pubmed-meshheading:8164024-Neutropenia,
pubmed-meshheading:8164024-Rifampin,
pubmed-meshheading:8164024-Stem Cell Transplantation,
pubmed-meshheading:8164024-Tobramycin,
pubmed-meshheading:8164024-Vancomycin
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support.
|
|
pubmed:affiliation |
Duke University Bone Marrow Transplant Program, Duke University Medical Center, Durham, NC 27710.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.
|
